Product Reports Resources Pricing Login Book a demo

Acerta Pharma

Biotech & Life Sciences · Oss, Netherlands · Founded 2013

Clinical research on cancer and autoimmune diseases

Investors

3 investors on Acerta Pharma's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Series A 2 investors entered at this stage
OrbiMed
Frazier Healthcare Partners

Global footprint

Where Acerta Pharma has talent and traffic

Workforce by country
11 countries with
team presence
🇳🇱 Netherlands78%
🇺🇸 United States9.5%
🇬🇧 United Kingdom2.9%
🇩🇪 Germany2.7%
🇫🇷 France1.7%
Top 5 of 11 shown
Web traffic by country
900 monthly visits
across markets
🇺🇸 United States66.7%
🇮🇳 India22.2%
🇳🇱 Netherlands11.1%
Top 3 markets shown

Talent graph

The shape of Acerta Pharma's talent

Dealroom maps Acerta Pharma's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

7 standout operatorsDealroom-flagged across the org
3 AI specialistsincl. 1 core researchers
141 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Acerta Pharma's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$41M patent portfolio · 26 active families

Estimated portfolio value
$41M
0.58% of valuation · 3.7× smaller than top peer Pharmacyclics ($150M)
26 active patent families
Where Acerta Pharma innovates Btk inhibitorsCancer researchCarcinosisDiseaseImidazole

Where Acerta Pharma concentrates vs peers

Each axis is a top-10 topic across Acerta Pharma and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Acerta Pharma

An AI-synthesized read of the highest-engagement posts about Acerta Pharma on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Acerta Pharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.